ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2211

Extracellular Vesicles from Cow Milk Accelerate Osteoblast Differentiation into Osteocytes, However, Type I Collagen Synthesis Is Reduced and Bone Matrix Organization Is Impaired

Marina C. Oliveira1, Onno J. Arntz1, Esmeralda Blaney Davidson1, Wim van den Berg1, Adaliene V.M. Ferreira2 and Fons A.J. van de Loo1, 1Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands, 2Department of Nutrition, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Bone, MicroRNA, nutrition and osteoblasts

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Biology and Pathology of Bone and Joint: Bone Remodeling and Metabolism

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Milk consumption during childhood stimulates bone growth but the claimed beneficial effect of milk on bone at adulthood is a matter of debate. Recently extracellular vesicles (EVs) that contain proteins and RNA were discovered in milk but their effect on bone formation has not yet been determined. Our aim was to evaluate the effect of bovine milk-derived EVs (BMEVs) on the differentiation of human mesenchymal stem cells (hMSCs) into osteoblasts, and on bone formation in mice.

Methods: hMSCs in osteogenic medium were treated with BMEVs (200µg/ml protein) and healthy female DBA1/J mice received orally two different particle concentrations of BMEVs 4.7×106/ml (low) or 14.3×106/ml (high) in their drink water during 7 weeks.

Results: Proteomic analysis in BMEVs showed the presence of proteins with a known effect on bone formation. The exposure of hMSCs to BMEVs during 21 days resulted in less mineralization but higher cell proliferation. Interestingly, BMEVs reduced the collagen production per cell, but enhanced the expression of osteoblast genes (Runx2, ALP, osteopontin, RANKL, FGF-2)  that are characteristic of immature osteoblasts. A kinetic study up to day 28 showed that BMEVs upregulated many osteogenic genes within the first 4 days of culture. However, the production of type I collagen and its genes (COL1A1 and COL1A2) were markedly reduced at days 21 and 28. At day 28, BMEVs again lead to higher proliferation, but mineralization that was lower at day 21 was significantly increased at day 28. Nonetheless the formation of bone nodules was impaired at day 28 and this was corroborated by a reduction in osteonectin expression. Moreover, BMEVs increased the expression of sclerostin, a marker gene of osteocytes at the same time point. Oral delivery of BMEVs to mice did not alter the tibia trabecular bone area, however the osteocytes numbers increased  independent of the dose. In addition, the highest dose of BMEVs reduced the adipose area in bone marrow of the femoral tibia bone and markedly increased the woven bone tissue and the number of osteoclasts by TRAP staining.

Conclusion: Our study showed that BMEVs on hMSCs increased osteoblast differentiation, proliferation and mineralization, probably by the induction of FGF-2 and WISP1. However, the lower type I collagen synthesis, and osteonectin expression could be explained by the presence of miR-29 in BMEVs. The net result of BMEVs exposure is impaired bone nodule formation in vitro and more woven bone formation in mice and this suggest that BMEVs could lead to more brittle bones. Our study add BMEVs to the list of milk components that can affect bone formation and may shed new light on the contradictory claims of milk on bone formation.


Disclosure: M. C. Oliveira, None; O. J. Arntz, None; E. Blaney Davidson, None; W. van den Berg, None; A. V.M. Ferreira, None; F. A. J. van de Loo, None.

To cite this abstract in AMA style:

C. Oliveira M, Arntz OJ, Blaney Davidson E, van den Berg W, V.M. Ferreira A, van de Loo FAJ. Extracellular Vesicles from Cow Milk Accelerate Osteoblast Differentiation into Osteocytes, However, Type I Collagen Synthesis Is Reduced and Bone Matrix Organization Is Impaired [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/extracellular-vesicles-from-cow-milk-accelerate-osteoblast-differentiation-into-osteocytes-however-type-i-collagen-synthesis-is-reduced-and-bone-matrix-organization-is-impaired/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/extracellular-vesicles-from-cow-milk-accelerate-osteoblast-differentiation-into-osteocytes-however-type-i-collagen-synthesis-is-reduced-and-bone-matrix-organization-is-impaired/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology